ABSCI CORP Depreciation
ABSCI CORP (ABSI) reported Depreciation of $8.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-24
- ABSCI CORP depreciation for the quarter ending 2024-12-31 was $2.40M, a 7.69% decline year-over-year.
- ABSCI CORP depreciation for the quarter ending 2024-09-30 was $2.50M, a 7.41% decline year-over-year.
- ABSCI CORP depreciation for the quarter ending 2023-12-31 was $2.60M, a 7.14% decline year-over-year.
- ABSCI CORP depreciation for the quarter ending 2023-09-30 was $2.70M, a 3.85% increase year-over-year.
- ABSCI CORP depreciation for fiscal 2025 was $8.40M, a 16.00% decline from fiscal 2024.
- ABSCI CORP depreciation for fiscal 2024 was $10.00M, a 5.66% decline from fiscal 2023.
- ABSCI CORP depreciation for fiscal 2023 was $10.60M, a 9.28% increase from fiscal 2022.
- ABSCI CORP depreciation for fiscal 2022 was $9.70M, a 115.56% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $8.40M 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $4.90M derived: sum of 2 quarters · filed 2026-03-24 | $10.00M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $2.50M 10-Q · filed 2024-11-12 | $7.60M 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $5.30M derived: sum of 2 quarters · filed 2025-03-18 | $8.00M derived: sum of 3 quarters · filed 2025-03-18 | $10.60M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.70M 10-Q · filed 2024-11-12 | $5.40M derived: sum of 2 quarters · filed 2024-11-12 | $8.00M 10-Q · filed 2024-11-12 | $10.90M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.70M 10-Q · filed 2023-08-14 | $5.30M 10-Q · filed 2023-08-14 | $8.20M derived: sum of 3 quarters · filed 2024-03-21 | $10.80M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-15 | $5.50M derived: sum of 2 quarters · filed 2024-03-21 | $8.10M derived: sum of 3 quarters · filed 2024-03-21 | $10.40M derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $5.40M derived: sum of 2 quarters · filed 2024-03-21 | $7.70M derived: sum of 3 quarters · filed 2024-03-21 | $9.70M 10-K · filed 2024-03-21 |
| 2022-09-30 | $2.60M 10-Q · filed 2023-11-14 | $4.90M derived: sum of 2 quarters · filed 2023-11-14 | $6.90M 10-Q · filed 2023-11-14 | $8.90M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $2.30M 10-Q · filed 2023-08-14 | $4.40M 10-Q · filed 2023-08-14 | $6.30M derived: sum of 3 quarters · filed 2023-08-14 | $7.70M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.10M 10-Q · filed 2023-05-15 | $4.00M derived: sum of 2 quarters · filed 2023-05-15 | $5.40M derived: sum of 3 quarters · filed 2023-05-15 | $6.30M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $3.30M derived: sum of 2 quarters · filed 2023-03-30 | $4.20M derived: sum of 3 quarters · filed 2023-03-30 | $4.50M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.40M 10-Q · filed 2022-11-09 | $2.30M derived: sum of 2 quarters · filed 2022-11-09 | $2.60M 10-Q · filed 2022-11-09 | $3.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $900.00K 10-Q · filed 2022-08-11 | $1.20M 10-Q · filed 2022-08-11 | $1.60M derived: sum of 3 quarters · filed 2022-08-11 | $1.90M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-11 | $700.00K derived: sum of 2 quarters · filed 2022-05-11 | $1.00M derived: sum of 3 quarters · filed 2022-05-11 | $1.30M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $600.00K derived: sum of 2 quarters · filed 2022-03-22 | $900.00K derived: sum of 3 quarters · filed 2022-03-22 | $1.10M 10-K · filed 2022-03-22 |
| 2020-09-30 | $300.00K 10-Q · filed 2021-11-09 | $600.00K derived: sum of 2 quarters · filed 2021-11-09 | $800.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $300.00K 10-Q · filed 2021-09-07 | $400.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |